BALLARD PARTNERS

Lobbying for LUPIN PHARMACEUTICALS INC. · Pharmaceutical manufacturer

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Maryland · $80,000.00 income · posted Oct 16, 2025

Lobbying activity 2

Trade (domestic/foreign)

Advocacy and guidance related to trade and tariffs. 232 Investigation.

Tariff (miscellaneous tariff bills)

Advocacy and guidance related to trade and tariffs. 232 Investigation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.